Funded Tech Companies
G1 Therapeutics
Operating out of Research Triangle Park, G1 Therapeutics raised its funding from MedImmune Ventures, Tavistock Life Sciences and Eshelman Ventures.
Company Overview
Company Name
G1 Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
700 Park Offices Dr. 200
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Company Background Information
Overview
G1 Therapeutics (Nasdaq: GTHX) is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of first-in-class compounds and best-in-class drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/17/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Velleca
Chief Medical Officer
Raj Malik
Chief Scientific Officer
Jay Strum
VP - Bus. Development
Mark Avagliano
VP - Bus. Development
John Demaree
VP - Operations
Terry Murdock
Company Investors
- MedImmune Ventures (Ronald Laufer)
- Tavistock Life Sciences
- Eshelman Ventures (Fred Eshelman)
- Cowen Capital Partners
- Hatteras Venture Partners (Christy Shaffer)
- Rock Springs Capital
- Mountain Group Capital
- RA Capital (Peter Kolchinsky)
- Lumira Capital
- AJU IB Investment
- Cormorant Asset Management (Bihua Chen)
- Franklin Templeton
- MedImmune Ventures (Michael Gutch)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs